Neil Finlayson

DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection

Janin Chandra, J.L. Dutton, Bo Li et al. · Journal of Immunotherapy · 2017 · 52 citations · Full text

An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1

J.L. Dutton, Wai-Ping Woo, Janin Chandra et al. · Human Vaccines & Immunotherapeutics · 2016 · 33 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +12

A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)

Janin Chandra, Wai-Ping Woo, Neil Finlayson et al. · Cancer Immunology Immunotherapy · 2020 · 32 citations · Full text

Vaccination, Vaccine Safety, Vaccine Research +13

Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial

Janin Chandra, Wai-Ping Woo, J.L. Dutton et al. · PLoS ONE · 2019 · 30 citations · Full text

Antibiotic-free production of a herpes simplex virus 2 DNA vaccine in a high yield cGMP process

Jared L. Nelson, Stephen A. Rodriguez, Neil Finlayson et al. · Human Vaccines & Immunotherapeutics · 2013 · 21 citations · Full text

Immunology, Glycoprotein D, Cgmp Production +19